Výsledky vyhledávání - "I. Rodriguez-Pubto"

POS0767 CLINICAL MANIFESTATIONS, TREATMENT, AND OUTCOMES OF 'NON-CRITERIA' ANTIPHOSPHOLIPID SYNDROME IN COMPARISON WITH DEFINITE ANTIPHOSPHOLIPID SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

Autor: G. Pires Da Rosa, B. Sousa-Pinto, Ricard Cervera, I. Rodriguez-Pubto, Paulo Bettencourt, Gerard Espinosa, Ester Ferreira

Publikováno v: Annals of the Rheumatic Diseases. 80:637-638

Background:Patients with laboratorial or clinical manifestations suggestive of antiphospholipid syndrome (APS) but not fulfilling the classification criteria [1] constitute a challenge in clinical practice.Objectives:To establish a comparison between

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d391f5be95bc3995a494f23edca8672a
https://doi.org/10.1136/annrheumdis-2021-eular.3353

Zobrazit plný text záznamu

POS0888 EPIDEMIOLOGICAL AND CLINICAL DIFFERENCES BETWEEN ANTI-MDA5 PHENOTYPES: DATA FROM A LARGE COHORT (MEDRA5) STUDY

Autor: X. Solanich, Fredeswinda Romero, M. E. Ruiz-Lucea, Ernesto Trallero-Araguás, Albert Selva-O'Callaghan, I. Rodriguez-Pubto, Ivan Castellví, O. Sanchez Pernaute, Santos Castañeda, Luis Sáez-Comet, R. Garcia de Vicuna, R. Coto-Hernández, Vera Ortiz-Santamaria, Á. Robles Marhuenda

Publikováno v: Annals of the Rheumatic Diseases. 80:700.1-700

Background:Idiopathic inflammatory myopathies are a heterogenous group of systemic autoimmune diseases. Several phenotypes have been linked to specific autoantibodies. Clinically amyopathic dermatomyositis with rapidly progressive interstitial lung d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b1950b84a3053f602ba7fe0763d8572e
https://doi.org/10.1136/annrheumdis-2021-eular.3837

Zobrazit plný text záznamu

THU0361 EPIDEMIOLOGIC VARIATION ON SCLERODERMA RENAL CRISIS AND CLINICAL FEATURES VARIATION ON SYSTEMIC SCLEROSIS PATIENTS OVER TIME: DATA FROM RESCLE REGISTRY

Autor: Eduardo L. Callejas-Moraga, I. Rodriguez-Pubto, Carmen Pilar Simeón-Aznar, M Freire, I. Pons Martin del Campo, A. Guillén del Castillo, M. E. Sánchez García, Luis Sáez-Comet, J. A. Todolí Parra, José Antonio Vargas-Hitos, V. Fonollosa-Pla, X. Pla Salas, L. Trapiella Martínez, C. Tolosa, J. Sánchez-Redondo

Publikováno v: Annals of the Rheumatic Diseases. 79:411.1-412

Background:Scleroderma renal crisis (SRC) prevalence is decreasing. However, no Systemic Sclerosis (SSc) patient’s registry has evaluated that decrease over time. No treatment have been able to prevent SRC development.Objectives:Primary objective:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c2badb1b2d4da3d6a6d1070cd9182c02
https://doi.org/10.1136/annrheumdis-2020-eular.1353

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání